A Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-7746 in Healthy Adult Subjects
Latest Information Update: 16 Dec 2015
At a glance
- Drugs NIP 022 (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 16 Dec 2015 New trial record